ITMCTR2000003979招募中1 期
Study for Chinese medicine Yiqi Huoxue Huaji decoction anti hepatitis B related liver cirrhosis based on multi-omics technology
Shenzhen Traditional Chinese Medicine Hospital0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 65（—）
- 性别
- All
入选标准
- •1. Meet the diagnostic criteria of traditional Chinese and Western medicine for severe liver fibrosis of hepatitis B in this study;
- •2. Aged 18-65 years old, without heart, brain, kidney and other diseases;
- •3. Those who are informed about this research, volunteer to take the test and sign the informed consent.
排除标准
- •1. Those who do not meet the diagnostic criteria of this study;
- •2. Those younger than 18 years old or above 65 years old;
- •3. Combined with alcoholic liver disease, non-alcoholic fatty liver disease, other viral hepatitis, autoimmune liver disease, parasitic disease and other specific liver diseases that can lead to cirrhosis;
- •4. Combined with severe primary diseases such as cardiovascular, brain, kidney, blood system and endocrine metabolism;
- •5. Pregnant or breastfeeding women;
- •6. Those who are known to have a history of allergies to the constituents of the research drug.
研究者
相似试验
尚未招募
1 期
Chinese Medicine in combination with western medicine for the prevention of relapse in patients with severe psoriasisITMCTR2000003295Guangdong Hospital of traditional Chinese Medicine
尚未招募
1 期
Chinese Medicine in combination with western medicine for the prevention of relapse in patients with severe psoriasisPsoriasisITMCTR2100005464Guangdong Provincial Hospital of Chinese Medicine
招募中
4 期
The clinical research of Yiqi Yangyin Huoxue Lishui combined with aflibercept on diabetic macular edemadiabetic macular edemaITMCTR2100004864Chongqing Aier Eye Hospital
已完成
1 期
Testifying Research Traditional Chinese Medicine Therapy supplementing Qi to Promote Body Fluid Production in Improving the Clinical Curative EffectITMCTR2000004149Xiyuan Hospital of China Academy of Traditional Chinese Medicine
已完成
2 期
''Highly exposed Chinese herbal medicine'' combined with apatinib as maintenance treatment following first-line or second-line chemotherapy for extensive-stage small-cell lung cancer: A single-armsmall cell lung cancerITMCTR2100004716The First Affiliated Hospital of Anhui Medical University